Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
1053668

C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022-2029
Published: | Polaris Market Research | 128 Pages | Delivery time: 1-2 business days

Price

Back to Top
C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022-2029
Published: January 1, 2022
Polaris Market Research
Content info: 128 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The global c-reactive protein testing market size is expected to reach USD 2,158.62 million by 2029 according to a new study by Polaris Market Research. The report "C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay); By Detection Range; By Disease Area; By End-Use; By Region; Segment Forecast, 2022 - 2029" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Increasing heart-related diseases due to the increasing geriatric population, obesity, and others are expected to increase the demand for the industry over the forecast period. Additionally, rising awareness for preventing and treating cardiovascular diseases, along with increasing investments for novel techniques, are expected to propel the industry over the forecast period.

Furthermore, the ongoing COVID-19 pandemic has increased the demand for innovative diagnosis with rapid results, has increased the demand for point-of-care testing, which in turn has benefited the industry and is expected to increase over the forecast period.

North America is expected to dominate the global market over the forecast period due to the presence of private and government reimbursement structures for these tests. For instance, in addition to payment for generic inflammatory screening, BlueCross BlueShield of North Carolina covers C-reactive protein tests in the detection of inflamed illnesses.

Some of the major players in the market include Abbott, Aidian, Abaxis, Inc., BODITECH MED, INC., F. Hoffmann-La Roche Ltd., Danaher, Thermo Fisher Scientific, Inc., Getein Biotech, Inc., Laboratory Corporation of America Holdings, HORIBA, Ltd., Merck KGaA, Quest Diagnostics, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Siemens Healthineers AG, Roche Ltd., and Zoetis.

Polaris Market Research has segmented the c-reactive protein testing market report on the basis of assay type, detection range, disease area, end-use, and region:

C-Reactive Protein Testing, Assay Type Outlook (Revenue - USD Million, 2017 - 2029)

Immuno-turbidimetric Assay

ELISA

Clinical

Non-clinical

Chemiluminescence Immunoassay

Others

C-Reactive Protein Testing, Detection Range Outlook (Revenue - USD Million, 2017 - 2029)

hs-CRP

Conventional CRP

cCRP

C-Reactive Protein Testing, Disease Area Outlook (Revenue - USD Million, 2017 - 2029)

Cardiovascular Diseases

Cancer

Rheumatoid Arthritis

Inflammatory Bowel Disease

Endometriosis

Lupus

Others

C-Reactive Protein Testing, End-Use Outlook (Revenue - USD Million, 2017 - 2029)

Clinics

Hospitals

Laboratories

Assisted Living Healthcare Facilities

Home Care Settings

Others

C-Reactive Protein Testing, Regional Outlook (Revenue - USD Million, 2017 - 2029)

North America

U.S.

Canada

Europe

Germany

UK

Italy

France

Spain

Austria

Netherlands

Asia Pacific

China

Japan

India

Indonesia

Malaysia

South Korea

Latin America

Brazil

Argentina

Mexico

Middle East & Africa

Israel

Saudi Arabia

South Africa

UAE

Product Code: PM1770

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global C-reactive protein Testing Market Insights

  • 4.1. C-reactive protein Testing - Industry Snapshot
  • 4.2. C-reactive protein Testing Market Dynamics
    • 4.2.1. Drivers and Opportunities
    • 4.2.2. Restraints and Challenges
    • 4.2.3. Porter's Five Forces Analysis
      • 4.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 4.2.3.2. Threats of New Entrants: (Low)
      • 4.2.3.3. Bargaining Power of Buyers (Moderate)
      • 4.2.3.4. Threat of Substitute (Moderate)
      • 4.2.3.5. Rivalry among existing firms (High)
    • 4.2.4. PESTLE Analysis
    • 4.2.5. C-reactive protein Testing Industry Trends
    • 4.2.6. COVID-19 Impact Analysis

5. Global C-reactive protein Testing Market, by Assay Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • 5.3. Immuno-turbidimetric Assay
    • 5.3.1. Global C-reactive protein Testing Market, by Immuno-turbidimetric Assay, by Region, 2017 - 2029 (USD Million)
  • 5.4. ELISA
    • 5.4.1. Global C-reactive protein Testing Market, by ELISA, by Region, 2017 - 2029 (USD Million)
    • 5.4.2. Clinical
      • 5.4.2.1. Global C-reactive protein Testing Market, by Clinical, by Region, 2017 - 2029 (USD Million)
    • 5.4.3. Non-clinical
      • 5.4.3.1. Global C-reactive protein Testing Market, by Non-clinical, by Region, 2017 - 2029 (USD Million)
  • 5.5. Chemiluminescence Immunoassay
    • 5.5.1. Global C-reactive protein Testing Market, by Chemiluminescence Immunoassay, by Region, 2017 - 2029 (USD Million)
  • 5.6. Others
    • 5.6.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)

6. Global C-reactive protein Testing Market, by Detection Range

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • 6.3. hs-CRP
    • 6.3.1. Global C-reactive protein Testing Market, by hs-CRP, by Region, 2017 - 2029 (USD Million)
  • 6.4. Conventional CRP
    • 6.4.1. Global C-reactive protein Testing Market, by Conventional CRP, by Region, 2017 - 2029 (USD Million)
  • 6.5. cCRP
    • 6.5.1. Global C-reactive protein Testing Market, by cCRP, by Region, 2017 - 2029 (USD Million)

7. Global C-reactive protein Testing Market, by Disease Area

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • 7.3. Cardiovascular Diseases
    • 7.3.1. Global C-reactive protein Testing Market, by Cardiovascular Diseases, By Region, 2017 - 2029 (USD Million)
  • 7.4. Cancer
    • 7.4.1. Global C-reactive protein Testing Market, by Cancer, By Region, 2017 - 2029 (USD Million)
  • 7.5. Rheumatoid Arthritis
    • 7.5.1. Global C-reactive protein Testing Market, by Rheumatoid Arthritis, By Region, 2017 - 2029 (USD Million)
  • 7.6. Inflammatory Bowel Disease
    • 7.6.1. Global C-reactive protein Testing Market, by Inflammatory Bowel Disease, By Region, 2017 - 2029 (USD Million)
  • 7.7. Endometriosis
    • 7.7.1. Global C-reactive protein Testing Market, by Endometriosis, By Region, 2017 - 2029 (USD Million)
  • 7.8. Lupus
    • 7.8.1. Global C-reactive protein Testing Market, by Lupus, By Region, 2017 - 2029 (USD Million)

8. Global C-reactive protein Testing Market, by End-Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • 8.3. Clinics
    • 8.3.1. Global C-reactive protein Testing Market, By Clinics, By Region, 2017 - 2029 (USD Million)
  • 8.4. Hospitals
    • 8.4.1. Global C-reactive protein Testing Market, by Hospitals, by Region, 2017 - 2029 (USD Million)
  • 8.5. Laboratories
    • 8.5.1. Global C-reactive protein Testing Market, by Laboratories, by Region, 2017 - 2029 (USD Million)
  • 8.6. Assisted Living Healthcare Facilities
    • 8.6.1. Global C-reactive protein Testing Market, by Assisted Living Healthcare Facilities, by Region, 2017 - 2029 (USD Million)
  • 8.7. Home Care Settings
    • 8.7.1. Global C-reactive protein Testing Market, by Home Care Settings, by Region, 2017 - 2029 (USD Million)
  • 8.8. Others
    • 8.8.1. Global C-reactive protein Testing Market, by Others, by Region, 2017 - 2029 (USD Million)

9. Global C-reactive protein Testing Market, by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
  • 9.3. C-reactive protein Testing Market - North America
    • 9.3.1. North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
    • 9.3.2. North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
    • 9.3.3. North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
    • 9.3.4. North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.3.5. C-reactive protein Testing Market - U.S.
      • 9.3.5.1. U.S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.3.5.2. U.S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.3.5.3. U.S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.3.5.4. U.S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.3.6. C-reactive protein Testing Market - Canada
      • 9.3.6.1. Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.3.6.2. Canada.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.3.6.3. Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.3.6.4. Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • 9.4. C-reactive protein Testing Market - Europe
    • 9.4.1. Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
    • 9.4.2. Europe.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
    • 9.4.3. Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
    • 9.4.4. Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.5. C-reactive protein Testing Market - UK
      • 9.4.5.1. UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.5.2. UK.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.5.3. UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.5.4. UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.6. C-reactive protein Testing Market - France
      • 9.4.6.1. France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.6.2. France.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.6.3. France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.6.4. France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.7. C-reactive protein Testing Market - Germany
      • 9.4.7.1. Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.7.2. Germany.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.7.3. Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.7.4. Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.8. C-reactive protein Testing Market - Italy
      • 9.4.8.1. Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.8.2. Italy.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.8.3. Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.8.4. Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.9. C-reactive protein Testing Market - Spain
      • 9.4.9.1. Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.9.2. Spain.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.9.3. Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.9.4. Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.10. C-reactive protein Testing Market - Netherlands
      • 9.4.10.1. Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.10.2. Netherlands.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.10.3. Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.10.4. Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.4.11. C-reactive protein Testing Market - Austria
      • 9.4.11.1. Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.4.11.2. Austria.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.4.11.3. Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.4.11.4. Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • 9.5. C-reactive protein Testing Market - Asia Pacific
    • 9.5.1. Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
    • 9.5.2. Asia Pacific.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
    • 9.5.3. Asia pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
    • 9.5.4. Asia pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.5.5. C-reactive protein Testing Market - China
      • 9.5.5.1. China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.5.5.2. China.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.5.5.3. China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.5.5.4. China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.5.6. C-reactive protein Testing Market - India
      • 9.5.6.1. India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.5.6.2. India.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.5.6.3. India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.5.6.4. India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.5.7. C-reactive protein Testing Market - Malaysia
      • 9.5.7.1. Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.5.7.2. Malaysia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.5.7.3. Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.5.7.4. Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.5.8. C-reactive protein Testing Market - Japan
      • 9.5.8.1. Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.5.8.2. Japan.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.5.8.3. Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.5.8.4. Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.5.9. C-reactive protein Testing Market - Indonesia
      • 9.5.9.1. Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.5.9.2. Indonesia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.5.9.3. Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.5.9.4. Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.5.10. C-reactive protein Testing Market - South Korea
      • 9.5.10.1. South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.5.10.2. South Korea.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.5.10.3. South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.5.10.4. South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • 9.6. C-reactive protein Testing Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
    • 9.6.2. Middle East & Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
    • 9.6.3. Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
    • 9.6.4. Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.6.5. C-reactive protein Testing Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.6.5.2. Saudi Arabia.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.6.5.3. Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.6.5.4. Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.6.6. C-reactive protein Testing Market - UAE
      • 9.6.6.1. UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.6.6.2. UAE.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.6.6.3. UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.6.6.4. UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.6.7. C-reactive protein Testing Market - Israel
      • 9.6.7.1. Israel: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.6.7.2. Israel.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.6.7.3. Israel: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.6.7.4. Israel: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.6.8. C-reactive protein Testing Market - South Africa
      • 9.6.8.1. South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.6.8.2. South Africa.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.6.8.3. South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.6.8.4. South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • 9.7. C-reactive protein Testing Market - Latin America
    • 9.7.1. Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
    • 9.7.2. Latin America.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
    • 9.7.3. Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
    • 9.7.4. Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.7.5. C-reactive protein Testing Market - Mexico
      • 9.7.5.1. Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.7.5.2. Mexico.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.7.5.3. Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.7.5.4. Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.7.6. C-reactive protein Testing Market - Brazil
      • 9.7.6.1. Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.7.6.2. Brazil.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.7.6.3. Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.7.6.4. Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
    • 9.7.7. C-reactive protein Testing Market - Argentina
      • 9.7.7.1. Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
      • 9.7.7.2. Argentina.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
      • 9.7.7.3. Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
      • 9.7.7.4. Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Abaxis, Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Abbott
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Aidian
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BODITECH MED, INC
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Danaher
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. F. Hoffmann-La Roche Ltd.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Getein Biotech, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. HORIBA, Ltd.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Laboratory Corporation of America Holdings
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Merck KGaA
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Ortho Clinical Diagnostics
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Quest Diagnostics
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Randox Laboratories Ltd.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Roche Ltd.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Siemens Healthineers AG
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Thermo Fisher Scientific, Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Zoetis
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development

List of Tables

  • Table 1 Global C-reactive protein Testing Market, by Assay Type, by Region, 2017 - 2029 (USD Million)
  • Table 2 Global C-reactive protein Testing Market, by End-Use, by Region, 2017 - 2029 (USD Million)
  • Table 3 Global C-reactive protein Testing Market, by Detection Range, by Region, 2017 - 2029 (USD Million)
  • Table 4 Global C-reactive protein Testing Market, by Disease Area, by Region, 2017 - 2029 (USD Million)
  • Table 5 C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)
  • Table 6 North America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 7 North America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 8 North America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 9 North America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 10 U.S.: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 11 U.S.: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 12 U.S.: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 13 U.S.: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 14 Canada: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 15 Canada: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 16 Canada: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 17 Canada: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 18 Europe: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 19 Europe: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 20 Europe: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 21 Europe: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 22 Germany: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 23 Germany: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 24 Germany: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 25 Germany: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 26 France: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 27 France: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 28 France: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 29 France: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 30 UK: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 31 UK: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 32 UK: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 33 UK: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 34 Italy: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 35 Italy: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 36 Italy: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 37 Italy: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 38 Netherlands: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 39 Netherlands: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 40 Netherlands: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 41 Netherlands: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 42 Spain: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 43 Spain: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 44 Spain: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 45 Spain: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 46 Austria: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 47 Austria: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 48 Austria: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 49 Austria: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 50 Asia Pacific: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 51 Asia Pacific: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 52 Asia Pacific: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 53 Asia Pacific: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 54 China: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 55 China: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 56 China: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 57 China: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 58 Japan: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 59 Japan: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 60 Japan: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 61 Japan: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 62 India: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 63 India: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 64 India: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 65 India: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 66 Indonesia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 67 Indonesia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 68 Indonesia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 69 Indonesia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 70 Malaysia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 71 Malaysia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 72 Malaysia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 73 Malaysia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 74 South Korea: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 75 South Korea: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 76 South Korea: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 77 South Korea: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 78 Latin America: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 79 Latin America: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 80 Latin America: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 81 Latin America: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 82 Brazil: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 83 Brazil: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 84 Brazil: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 85 Brazil: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 86 Mexico: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 87 Mexico: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 88 Mexico: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 89 Mexico: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 90 Argentina: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 91 Argentina: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 92 Argentina: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 93 Argentina: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 94 Middle East & Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 95 Middle East & Africa: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 96 Middle East & Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 97 Middle East & Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 98 UAE: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 99 UAE: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 100 UAE: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 101 UAE: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 102 Saudi Arabia: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 103 Saudi Arabia: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 104 Saudi Arabia: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 105 Saudi Arabia: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 106 South Africa: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 107 South Africa: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 108 South Africa: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 109 South Africa: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)
  • Table 110 Isreal: C-reactive protein Testing Market, by Assay Type, 2017 - 2029 (USD Million)
  • Table 111 Isreal: C-reactive protein Testing Market, by End-Use, 2017 - 2029 (USD Million)
  • Table 112 Isreal: C-reactive protein Testing Market, by Detection Range, 2017 - 2029 (USD Million)
  • Table 113 Isreal: C-reactive protein Testing Market, by Disease Area, 2017 - 2029 (USD Million)

List of Figures

Figure 1. Global C-reactive protein Testing Market, 2017 - 2029 (USD Million)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Assay Type

Figure 7. Global C-reactive protein Testing Market, by Assay Type, 2020 & 2029 (USD Million)

Figure 8. Market by End-Use

Figure 9. Global C-reactive protein Testing Market, by End-Use, 2020 & 2029 (USD Million)

Figure 10. Market by Detection Range

Figure 11. Global C-reactive protein Testing Market, by Detection Range, 2020 & 2029 (USD Million)

Figure 12. Market by Disease Area

Figure 13. Global C-reactive protein Testing Market, by Disease Area, 2020 & 2029 (USD Million)

Figure 14. C-reactive protein Testing Market Assessment, By Geography, 2017 - 2029 (USD Million)

Figure 15. Strategic Analysis - C-reactive protein Testing Market